Dr Martens shares plunged around 30 percent on Tuesday to a record low after the British boot maker warned of another tough year in its key US market, setting a challenge for its next chief executive.
The company, whose chunky lace-up boots have been a fashion statement since the 1960s, named chief brand officer Ije Nwokorie as its next CEO.
Kenny Wilson, who has been at the helm for six years, has decided this year will be his last as CEO, Dr Martens said, although it did not give a precise date for the handover.
The company has been struggling with customer destocking and reduced orders in the United States from wholesale customers wary of economic pressures.
Its shares have been hammered in recent years by a series of profit warnings and disappointing results that prompted investor Marathon Partners to call for an immediate strategic review earlier this month.
They hit a record low of 65.50 pence in early Tuesday trade.
Dr Martens said its results for the year ended March 31, 2024, would be in line with market expectations, but flagged another difficult year ahead.
“The FY25 outlook is challenging, and the whole organisation is focused on our action plan to reignite boots demand, particularly in the USA, our largest market,” Wilson said.
“The nature of USA wholesale is that when customers gain confidence in the market we will see a significant improvement in our business performance, but we are not assuming that this occurs in FY25.”
The company said it was anticipating a double-digit percentage decline in US wholesale revenues, which would dent overall profits.
It also said it did not expect to hike prices further this year, which had previously enabled it to offset cost inflation.
By Yadarisa Shabong and Eva Mathews; editing by Janane Venkatraman and Mark Potter
Learn more:
Marathon Partners Pushes Dr. Martens for Strategic Review, Possible Sale
Investment firm Marathon Partners Equity Management wants British boot maker Dr. Martens to hire bankers and begin an immediate strategic review that could lead to a sale of the company, according to a letter seen by Reuters.
